ADGM
Adagio Medical Holdings, Inc.1.1800
+0.3487+41.9%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
24.99MP/E (TTM)
-Basic EPS (TTM)
-2.69Dividend Yield
0%Recent Filings
8-K
Annual meeting elects directors
Adagio Medical Holdings held its 2025 Annual Meeting on December 15, with 65.45% of shares present. Stockholders elected Todd Usen and James L. Cox, M.D., as directors until 2028—Usen with 12.9M for votes, Cox with 11.6M. They ratified WithumSmith+Brown, PC as auditors for 2025, passing 13.4M for versus 353K against. Governance locked in.
8-K
Board adds Medtronic veteran
Adagio Medical Holdings expanded its board from six to seven directors on December 11, 2025, appointing Sean Salmon, ex-Medtronic Cardiovascular Portfolio president, as a Class II director through the 2026 annual meeting. He joins the Audit and Compensation Committees, bringing deep medtech experience from Medtronic, Bard, and J&J. Standard director pay and indemnification apply. No related arrangements disclosed.
8-K
Q3 loss widens; $50M financing
Adagio Medical reported Q3 2025 net loss of $10.1 million, up from $4.6 million last year, with cash at $4.7 million as of September 30. Yet it closed a $50 million private placement on October 20—$19 million upfront—to fund FDA PMA submission for vCLAS after completing FULCRUM-VT enrollment and posting 97% acute effectiveness. Cash burn accelerates. Leadership added CFO Deborah Kaster.
10-Q
Q3 FY2025 results
Adagio Medical Holdings posted no revenue for Q3 ended September 30, 2025, down from $132K y/y (Successor) amid a European commercial pause, yet R&D ticked up 12.4% y/y to $2.8M on FULCRUM-VT trial momentum. Operating loss widened to $5.7M from $4.4M y/y, with net loss at $10.1M versus $3.6M profit y/y, as $3.5M convertible notes fair-value hit and $0.7M interest overwhelmed prior gains. Cash burned to $4.7M from $20.6M year-start, with $14.9M YTD operating use; $21.2M debt looms. Cash is tight.
8-K
2025 AGM date set
ADAG
Adagene Inc.
1.90+0.23
AEMD
Aethlon Medical, Inc.
2.94-0.11
BDMD
Baird Medical Investment Holdin
1.37+0.02
ICCM
IceCure Medical Ltd.
0.63-0.01
IRTC
iRhythm Technologies, Inc.
167.90-1.10
MODD
Modular Medical, Inc.
0.34-0.03
NVNO
enVVeno Medical Corporation
0.32+0.01
ODYY
Odyssey Health Inc.
0.03+0.00
PMI
Picard Medical, Inc.
2.30-0.13
SENS
Senseonics Holdings, Inc.
6.62-0.17